Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 457

1.

The insulin-like growth factor system and cancer.

LeRoith D, Roberts CT Jr.

Cancer Lett. 2003 Jun 10;195(2):127-37. Review.

PMID:
12767520
2.

Insulin-like growth factors and their binding proteins in prostate cancer: cause or consequence?

Meinbach DS, Lokeshwar BL.

Urol Oncol. 2006 Jul-Aug;24(4):294-306. Review.

PMID:
16818181
3.
4.

Insulin-like growth factors induce apoptosis as well as proliferation in LIM 1215 colon cancer cells.

Fu P, Thompson JA, Leeding KS, Bach LA.

J Cell Biochem. 2007 Jan 1;100(1):58-68.

PMID:
16888814
5.

Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.

Schlenska-Lange A, Knüpfer H, Lange TJ, Kiess W, Knüpfer M.

Anticancer Res. 2008 Mar-Apr;28(2A):1055-60. Erratum in: Anticancer Res. 2008 May-Jun;28(3b):1965.

7.

Insulin-like growth factors.

LeRoith D, McGuinness M, Shemer J, Stannard B, Lanau F, Faria TN, Kato H, Werner H, Adamo M, Roberts CT Jr.

Biol Signals. 1992 Jul-Aug;1(4):173-81. Review.

PMID:
1307923
8.

Involvement of insulin-like growth factors-I and -II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas.

Elizalde PV, Lanari C, Molinolo AA, Guerra FK, Balañá ME, Simian M, Iribarren AM, Charreau EH.

J Steroid Biochem Mol Biol. 1998 Nov;67(4):305-17.

PMID:
9883987
9.

Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors.

Siddle K, Ursø B, Niesler CA, Cope DL, Molina L, Surinya KH, Soos MA.

Biochem Soc Trans. 2001 Aug;29(Pt 4):513-25. Review.

PMID:
11498020
10.

The anabolic effects of GH/IGF system on bone.

Kasukawa Y, Miyakoshi N, Mohan S.

Curr Pharm Des. 2004;10(21):2577-92. Review.

PMID:
15320746
11.

The role of the IGF axis in hepatocarcinogenesis.

Scharf JG, Braulke T.

Horm Metab Res. 2003 Nov-Dec;35(11-12):685-93. Review.

PMID:
14710347
12.

Insulin-like growth factor 1 and hair growth.

Su HY, Hickford JG, Bickerstaffe R, Palmer BR.

Dermatol Online J. 1999 Nov;5(2):1.

PMID:
10673454
13.

A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivo.

Ji QS, Mulvihill MJ, Rosenfeld-Franklin M, Cooke A, Feng L, Mak G, O'Connor M, Yao Y, Pirritt C, Buck E, Eyzaguirre A, Arnold LD, Gibson NW, Pachter JA.

Mol Cancer Ther. 2007 Aug;6(8):2158-67. Epub 2007 Aug 1.

14.
15.
16.
17.

Energy balance and cancer: the role of insulin and insulin-like growth factor-I.

Kaaks R, Lukanova A.

Proc Nutr Soc. 2001 Feb;60(1):91-106. Review.

PMID:
11310428
18.

Growth hormone and insulin-like growth factor-I: effects on the growth of glioma cell lines.

Friend KE, Khandwala HM, Flyvbjerg A, Hill H, Li J, McCutcheon IE.

Growth Horm IGF Res. 2001 Apr;11(2):84-91.

PMID:
11472074
19.

The insulin-like growth factor axis in cell cycle progression.

Dupont J, Pierre A, Froment P, Moreau C.

Horm Metab Res. 2003 Nov-Dec;35(11-12):740-50. Review.

PMID:
14710353
20.

Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.

Avnet S, Sciacca L, Salerno M, Gancitano G, Cassarino MF, Longhi A, Zakikhani M, Carboni JM, Gottardis M, Giunti A, Pollak M, Vigneri R, Baldini N.

Cancer Res. 2009 Mar 15;69(6):2443-52. doi: 10.1158/0008-5472.CAN-08-2645. Epub 2009 Mar 3.

Supplemental Content

Support Center